Valuation: Novartis AG

Market Cap 281B 246B 228B 210B 397B 26,869B 405B 2,718B 1,066B 13,195B 1,054B 1,031B 45,568B P/E 2026 *
21.4x
P/E 2027 * 18.1x
Enterprise Value 313B 274B 254B 234B 442B 29,932B 451B 3,028B 1,188B 14,699B 1,174B 1,149B 50,763B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 5.13x
Free-Float
91.66%
Yield 2026 *
2.87%
Yield 2027 * 2.96%
1 day-1.97%
1 week-3.45%
Current month-3.29%
1 month+1.83%
3 months+1.78%
6 months+5.48%
Current year+11.70%
1 week 122.02
Extreme 122.02
126.52
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
05-18Sell -5,200 0.0003%
05-04Sell 6,800 0.0003%
02-17Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.73%-3.45%+26.95%+44.09% 281B
-2.49%-6.72%+44.19%+156.44% 1,054B
-1.83%-5.28%+61.41%+58.33% 621B
-1.26%-3.95%+27.71%+79.83% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.41%-3.37%+19.75%+56.40% 195B
-0.89%-4.45%+16.24%+68.79% 163B
-0.96%+0.77%-4.32%-33.22% 140B
Average -1.55%-1.21%+20.69%+43.11% 369.57B
Weighted average by Cap. -1.81%-1.50%+31.68%+72.81%

Financials

2026 *2027 *
Net sales 56.83B 49.84B 46.16B 42.47B 80.34B 5,439B 81.9B 550B 216B 2,671B 213B 209B 9,224B 60.24B 52.84B 48.94B 45.03B 85.17B 5,766B 86.83B 583B 229B 2,831B 226B 221B 9,778B
Net income 14.08B 12.35B 11.44B 10.52B 19.9B 1,348B 20.29B 136B 53.46B 662B 52.87B 51.71B 2,285B 15.64B 13.72B 12.71B 11.69B 22.12B 1,497B 22.55B 151B 59.4B 735B 58.74B 57.46B 2,539B
Net Debt 32B 28.07B 26B 23.92B 45.25B 3,063B 46.13B 310B 122B 1,504B 120B 118B 5,195B 28.5B 25B 23.15B 21.3B 40.3B 2,728B 41.08B 276B 108B 1,340B 107B 105B 4,627B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
14/07/26 CHF 122.42 -1.73% 2,431,098
13/07/26 CHF 124.58 +0.24% 2,143,959
10/07/26 CHF 124.28 -0.02% 2,334,841
09/07/26 CHF 124.30 -1.27% 2,233,204
08/07/26 CHF 125.90 -0.71% 2,243,169
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
153.36USD
Average target price
153.30USD
Spread / Average Target
-0.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock